Skip to main content
    E

    Entera Bio Ltd (ENTX)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $3.02
    -0.09 (-2.89%)

    Market Cap: $541.57M

    Last updated: Nov 17, 2026 at 11:04 AM ET

    Entera Bio Ltd (ENTX) Earnings: Report Dates and Results

    Updated Nov 6, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    Entera Bio (ENTX) is expected to report earnings on Mar 25, 2027. In the quarter ended Sep 30, 2026, Entera Bio reported EPS of -$0.11, below the -$0.07 estimate. It beat the EPS estimate in 6 of the last 8 quarters.

    Earnings

    Performance (10Y)

    Beat Rate
    61%(20/33)
    Avg Surprise
    -8.10%

    Upcoming Estimates

    Reports Mar 25, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus-$0.14
    Range-$0.21 - -$0.05
    7 analysts
    Revenue Consensus
    N/A
    RangeN/A
    6 analysts
    Reports May 6, 2027 (est.)Period ending Mar 31, 2027
    EPS Consensus-$0.13
    Range-$0.13 - -$0.12
    2 analysts
    EPS RevisionsNo revisions (30d)
    EPS Estimate DriftChange to current
    90d ago-$0.13+3.8%
    60d ago-$0.13+3.8%
    30d ago-$0.12-8.7%
    7d ago-$0.12-8.7%
    Current-$0.13
    Revenue Consensus
    N/A
    RangeN/A
    2 analysts

    Next Report

    ENTX has an expected report date of Mar 25, 2027.

    Earnings History

    Of the 33 quarters below that had an estimate, ENTX beat 20, missed 11 and matched 2. The widest gap in the table came in the quarter ended Mar 31, 2021, when EPS landed 258.33% below the estimate.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReportedRevenue
    Sep 30, 2026-$0.11-$0.07-$0.09 - -$0.05-57.14%MissN/A50 up, 0 downNov 6, 2026N/A
    Jun 30, 2026-$0.14-$0.08-$0.08 - -$0.08-75.00%MissN/A11 up, 0 downAug 7, 2026N/A
    Mar 31, 2026-$0.07-$0.08-$0.08 - -$0.08+12.50%BeatN/A11 up, 0 downMay 8, 2026N/A
    Dec 31, 2025-$0.06-$0.11N/A+45.45%BeatN/A11 up, 0 downMar 27, 2026N/A
    Sep 30, 2025-$0.07-$0.09-$0.09 - -$0.09+22.22%BeatN/A11 up, 0 downNov 14, 2025N/A
    Jun 30, 2025-$0.06-$0.11N/A+45.45%BeatN/AN/A0 up, 0 downAug 8, 2025N/A
    Mar 31, 2025-$0.06-$0.07N/A+14.29%BeatN/AN/A0 up, 0 downMay 9, 2025$42000
    Dec 31, 2024-$0.06-$0.08N/A+25.00%BeatN/AN/A0 up, 0 downMar 28, 2025$82000
    Sep 30, 2024-$0.08-$0.05-$0.05 - -$0.05-60.00%MissN/A10 up, 0 downNov 8, 2024$42000
    Jun 30, 2024-$0.06-$0.06-$0.06 - -$0.060.00%In lineN/A10 up, 0 downAug 9, 2024$57000
    Mar 31, 2024-$0.05-$0.06-$0.06 - -$0.06+16.67%BeatN/A10 up, 0 downMay 10, 2024N/A
    Dec 31, 2023-$0.07-$0.08N/A+12.50%BeatN/AN/A0 up, 0 downMar 8, 2024$4.48M
    Sep 30, 2023-$0.08-$0.09-$0.09 - -$0.09+11.11%BeatN/A10 up, 0 downNov 14, 2023N/A
    Jun 30, 2023-$0.08-$0.07-$0.07 - -$0.07-14.29%MissN/A10 up, 0 downAug 11, 2023N/A
    Mar 31, 2023-$0.08-$0.12-$0.12 - -$0.12+33.33%BeatN/A10 up, 0 downMay 5, 2023N/A
    Dec 31, 2022-$0.10-$0.11-$0.12 - -$0.11+9.09%BeatN/A20 up, 0 downMar 27, 2023$14000
    Sep 30, 2022-$0.11-$0.13-$0.16 - -$0.11+15.38%BeatN/A20 up, 0 downNov 10, 2022$8000
    Jun 30, 2022-$0.11-$0.16-$0.24 - -$0.10+31.25%BeatN/A41 up, 0 downAug 11, 2022$44000
    Mar 31, 2022-$0.13-$0.18-$0.20 - -$0.16+27.78%BeatN/A30 up, 0 downMay 12, 2022$68000
    Dec 31, 2021-$0.21-$0.23-$0.46 - -$0.11+8.70%BeatN/A3N/AMar 8, 2022$165000
    Sep 30, 2021-$0.05-$0.11-$0.13 - -$0.10+54.55%BeatN/A21 up, 0 downNov 10, 2021$140000
    Jun 30, 2021-$0.21-$0.12-$0.14 - -$0.10-75.00%MissN/A3N/AAug 16, 2021$109000
    Mar 31, 2021-$0.43-$0.12-$0.12 - -$0.12-258.33%Miss-368.7%1N/AMay 20, 2021$157000
    Dec 31, 2020-$0.13-$0.14-$0.14 - -$0.14+7.14%BeatN/A1N/AMar 18, 2021$221000
    Sep 30, 2020-$0.09-$0.20-$0.20 - -$0.20+55.00%BeatN/A1N/ANov 19, 2020$50000
    Jun 30, 2020-$0.17-$0.12N/A-41.67%MissN/AN/AN/AAug 20, 2020$52000
    Mar 31, 2020$0.16N/AN/AN/AN/AN/AN/AN/AMay 21, 2020$42000
    Dec 31, 2019-$0.26-$0.19N/A-36.84%MissN/AN/AN/AMar 26, 2020$102000
    Sep 30, 2019-$0.25-$0.15-$0.15 - -$0.15-66.67%MissN/A1N/ANov 21, 2019$60000
    Jun 30, 2019-$0.12-$0.28-$0.28 - -$0.28+57.14%BeatN/A1N/AAug 20, 2019$74000
    Mar 31, 2019-$0.26N/AN/AN/AN/AN/AN/AN/AJun 27, 2019$74000
    Dec 31, 2018-$0.17-$0.35-$0.35 - -$0.35+51.43%BeatN/A1N/AJan 22, 2019$500000
    Sep 30, 2018-$0.45-$0.28N/A-60.71%MissN/AN/AN/ASep 30, 2018N/A
    Jun 30, 2018-$0.16-$0.09N/A-77.78%MissN/AN/AN/AAug 20, 2018N/A
    Mar 31, 2018-$0.08-$0.08-$0.08 - -$0.080.00%In lineN/A1N/AJun 29, 2018N/A
    Dec 31, 2017-$0.31N/AN/AN/AN/AN/AN/AN/AMar 30, 2018N/A
    Sep 30, 2017-$0.19N/AN/AN/AN/AN/AN/AN/ANov 9, 2017N/A
    Mar 31, 2017-$0.13N/AN/AN/AN/AN/AN/AN/AJun 29, 2017N/A
    Dec 31, 2016-$0.07N/AN/AN/AN/AN/AN/AN/AMar 30, 2017N/A
    Sep 30, 2016-$0.15N/AN/AN/AN/AN/AN/AN/ANov 4, 2016N/A
    Last 40 quarters

    Annual EPS

    EPS for the fiscal year ended Dec 31, 2025 was -$0.25, after -$0.25 the year before. It was -$0.22 for the year ended Dec 31, 2016, the oldest of the 10 fiscal years shown.

    Fiscal year endedEPSChange
    Dec 31, 2025-$0.25N/A
    Dec 31, 2024-$0.25N/A
    Dec 31, 2023-$0.31N/A
    Dec 31, 2022-$0.45N/A
    Dec 31, 2021-$0.90N/A
    Dec 31, 2020-$0.23N/A
    Dec 31, 2019-$0.89N/A
    Dec 31, 2018-$0.86N/A
    Dec 31, 2017-$0.63N/A
    Dec 31, 2016-$0.22N/A

    Frequently Asked Questions About ENTX

    When is Entera Bio's next earnings date?

    Entera Bio's next earnings report is expected for Mar 25, 2027.

    Did ENTX beat earnings estimates last quarter?

    No. Entera Bio reported EPS of -$0.11 for the quarter ended Sep 30, 2026, below the -$0.07 estimate by 57.14%.

    What EPS do analysts expect from ENTX next quarter?

    The consensus EPS estimate for Entera Bio for the quarter ending Dec 31, 2026 is -$0.14 from 7 analysts, with estimates from -$0.21 to -$0.05.

    How often does ENTX beat earnings estimates?

    Entera Bio beat the EPS estimate in 6 of the last 8 quarters, with an average surprise of +4.10%.